TrialClinical pharmacokinetics2017

Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.

Stephan Glund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.